Daniel Ghinn discusses the possible positive outcomes to Boehringer Ingelheim’s Syrum, the highly-anticipated pharmaceutical social game, ahead of its launch this week. Ever since Boehringer ...

Boehringer Ingelheim was an early adopter of Medidata's electronic data collection (EDC) platform for clinical trials, and has now extended and expanded the contract. The new five-year alliance ...

Boehringer Ingelheim Pharma GmbH & Co KG has selected a third oncology drug candidate to advance into IND-enabling studies under its ongoing collaboration with Oxford Biotherapeutics Ltd.

Boehringer Ingelheim launches three-in-one poultry vaccine to ease operational burden on farms Wednesday, 18 June, 2025, 14 : 00 PM [IST] Our Bureau, Bengaluru Boehringer Ingelheim, a global leader in ...

Dr. Pavol Dobrocky, president and CEO of Boehringer Ingelheim China. [Photo provided to chinadaily.com.cn] Boehringer Ingelheim remains confident about its future business development in China, which ...